The ExoAtlet II is intended for use as a gait training and rehabilitation device to improve gait function and independence in patients with neurological or muscular injuries, diseases or weaknesses.
Everything you need to know about the features and benefits of the The ExoAtlet II: Exoskeleton for rehabilitation training as a therapeutic trainer in rehabilitation clinics. need to know.
The ExoAtlet II's 13 anthropometric settings allow customization to each patient's physical conditions, including adduction and abduction of the thigh and inversion and eversion of the foot.
ExoAtlet II is a therapeutic trainer and is used in rehabilitation. ExoAtlet II can improve walking and create more independence for patients who have neurological damage or muscular injury, disease or weakness. ExoAtlet II has CE certification and ISO:13485 certification.
Can't find the answer to your question? Contact us.
The company has offices in China, Japan, Korea, USA and Luxenburg. ExoAtlet has received a total of $ 8.3 million in 3 rounds of funding. The latest funding was raised on April 3, 2018 in a Series B round. ExoAtlet is funded by 4 investors. VEB Ventures and Korean Cosmo & Company are the most recent investors.
Image sources: All images and graphics are copyrighted and property of ©.
ExoAtlet Global SA.